TATACHEM — Tata Chemicals Balance Sheet
0.000.00%
- IN₹203.91bn
- IN₹276.37bn
- IN₹148.87bn
- 74
- 35
- 66
- 64
Annual balance sheet for Tata Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 29,543 | 26,157 | 19,160 | 12,420 | 14,010 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 17,454 | 23,766 | 32,430 | 22,310 | 22,680 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 66,457 | 87,450 | 81,640 | 63,670 | 67,200 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 66,792 | 77,899 | 89,200 | 94,270 | 106,730 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 283,372 | 338,433 | 350,840 | 367,560 | 377,800 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 44,634 | 70,960 | 49,040 | 60,550 | 61,390 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 140,472 | 155,904 | 153,630 | 145,150 | 161,860 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 142,900 | 182,529 | 197,210 | 222,410 | 215,940 |
| Total Liabilities & Shareholders' Equity | 283,372 | 338,433 | 350,840 | 367,560 | 377,800 |
| Total Common Shares Outstanding |